Abstract:BackgroundAdverse Drug Reactions (ADRs) are of great public health concern. FDA-approved drug labeling summarizes ADRs of a drug product mainly in three sections, i.e., Boxed Warning (BW), Warnings and Precautions (WP), and Adverse Reactions (AR), where the severity of ADRs are intended to decrease in the order of BW>WP>AR. Several reported studies have extracted ADRs from labeling documents, but most, if not all, did not discriminate the severity of the ADRs by the different labeling sections. Such a practice could overstate or underestimate the impact of certain ADRs to the public health. In this study, we applied the Medical Dictionary for Regulatory Activities (MedDRA) to drug labeling and systematically analyzed and compared the ADRs from the three labeling sections with a specific emphasis on analyzing serious ADRs presented in BW, which is of most drug safety concern.ResultsThis study investigated New Drug Application (NDA) labeling documents for 1164 single-ingredient drugs using Oracle Text search to extract MedDRA terms. We found that only a small portion of MedDRA Preferred Terms (PTs), 3819 out of 21,920 or 17.42%, were observed in a whole set of documents. In detail, 466/3819 (12.0%) PTs were in BW, 2023/3819 (53.0%) were in WP, and 2961/3819 (77.5%) were in AR sections. We also found a higher overlap of top 20 occurring BW PTs with WP sections compared to AR sections. Within the MedDRA System Organ Class levels, serious ADRs (sADRs) from BW were prevalent in Nervous System disorders and Vascular disorders. A Hierarchical Cluster Analysis (HCA) revealed that drugs within the same therapeutic category shared the same ADR patterns in BW (e.g., nervous system drug class is highly associated with drug abuse terms such as dependence, substance abuse, and respiratory depression).ConclusionsThis study demonstrated that combining MedDRA standard terminologies with data mining techniques facilitated computer-aided ADR analysis of drug labeling. We also highlighted the importance of labeling sections that differ in seriousness and application in drug safety. Using sADRs primarily related to BW sections, we illustrated a prototype approach for computer-aided ADR monitoring and studies which can be applied to other public health documents.

MaLDA:medication analysis based on LDA

Study of Serious Adverse Drug Reactions Using FDA-approved Drug Labeling and MedDRA

Measure Clinical Drug-Drug Similarity Using Electronic Medical Records.

A Method of Automatic Annotation for Medical Record Text Based on Latent Dirichlet Allocation

MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes

Medical Aided Diagnosis Using Electronic Medical Records Based On Lda And Word Vector Model

Drug Efficacy Prediction in Tumors Based on LDA Model

Learning from low-rank multimodal representations for predicting disease-drug associations

MLRDA: A Multi-Task Semi-Supervised Learning Framework for Drug-Drug Interaction Prediction

MALADE: Orchestration of LLM-powered Agents with Retrieval Augmented Generation for Pharmacovigilance

MD-LDA: a Supervised LDA Topic Model for Identifying Mechanism of Disease in TCM

Enhancing Medication Safety with Large Language Models: Advanced Detection and Prediction of Drug-Drug Interactions

Medical Record Semantic Analysis Based on Weighted LDA

ShennongMGS: An LLM-based Chinese Medication Guidance System

An End-to-end Hybrid Algorithm for Automated Medication Discrepancy Detection

Medical Record Text Analysis Based on Latent Semantic Analysis

[Exploration on Rationality Evaluation Approach of Drug Combination Medication Based on Sequential Analysis and Machine Learning].

Developing large language models to detect adverse drug events in posts on x

StratMed: Relevance stratification between biomedical entities for sparsity on medication recommendation

Probabilistic-Mismatch Anomaly Detection: Do One’s Medications Match with the Diagnoses